USPH 8-K: Conference call transcript for Q3 and nine months 2025

Rhea-AI Filing Summary

U.S. Physical Therapy, Inc. furnished a conference call transcript as Exhibit 99.1 under Item 7.01 (Regulation FD). The call, held on November 6, 2025, discussed results for the three and nine months ended September 30, 2025.

The company states the information is furnished, not filed, is not subject to Section 18 of the Exchange Act, and will not be incorporated by reference into Securities Act or Exchange Act filings except as expressly set forth by specific reference.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

falseU S PHYSICAL THERAPY INC /NV0000885978NYSE00008859782025-11-062025-11-060000885978usph:NYSEMember2025-11-062025-11-060000885978usph:NewYorkStockExchangeMember2025-11-062025-11-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

 CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 6, 2025

 U.S. PHYSICAL THERAPY, INC.

(Exact name of registrant as specified in its charter)

Nevada		001-11151		76-0364866
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(I.R.S. Employer Identification No.)

1300 WEST SAM HOUSTON PARKWAY, SUITE 300, HOUSTON, Texas		77043
(Address of Principal Executive Offices)		(Zip Code)

Registrant's telephone number, including area code: (713) 297-7000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $.01 par value	USPH	New York Stock Exchange
Common Stock, $.01 par value	USPH	NYSE Texas, Inc.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

ITEM 7.01 Regulation FD Disclosure.
 

On November 6, 2025 – U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, hosted a conference call and webcast to discuss its results for the three and nine months ended September 30, 2025. The transcript of the conference call is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Current Report on Form 8-K, including the exhibits, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

ITEM 9.01   FINANCIAL STATEMENTS AND EXHIBITS

Exhibit		Description of Exhibit
99.1		Registrant's November 6, 2025 Conference Call Transcript Discussing Three and Nine months ended September 30, 2025

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

				U.S. PHYSICAL THERAPY, INC.
Dated: November 11, 2025				By:		/s/ CAREY HENDRICKSON
						Carey Hendrickson
						Chief Financial Officer
						(duly authorized officer and principal financial and accounting officer)

FAQ

What did USPH (NYSE: USPH) report in this 8-K?

USPH furnished its November 6, 2025 conference call transcript as Exhibit 99.1 under Item 7.01 (Reg FD).

Which period did the USPH call address?

The call discussed results for the three and nine months ended September 30, 2025.

Is the information considered 'filed' with the SEC?

No. The information is furnished, not filed, and is not subject to Section 18 liabilities.

Will the transcript be incorporated by reference into other filings?

It will not be incorporated by reference unless expressly set forth by specific reference in another filing.

Where is the transcript located in the 8-K?

It is included as Exhibit 99.1 titled “Registrant's November 6, 2025 Conference Call Transcript.”

What item of Form 8-K does this relate to?

This pertains to Item 7.01: Regulation FD Disclosure.